SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This is a Form 8-K Current Report filed by BioSig Technologies, Inc. (not Streamex Corp.) on September 18, 2018. The registrant is incorporated in Delaware and headquartered in Los Angeles, California. The filing serves as a Regulation FD disclosure regarding the distribution of an investor presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing to disclose the existence of an attached presentation (Exhibit 99.1) rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this specific filing. The report solely announces the intent to distribute an investor presentation to the investment community and at industry conferences.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to utilize the attached slide presentation for investor relations purposes.
- Legal Disclaimer: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials in Exhibit 99.1.
- Liability Limitation: Information in this Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section.
- Materiality: The furnishing of this information is not intended to constitute a determination that the content is material or required by Regulation FD.
Investor Verification Checklist
- Verify the actual content of Exhibit 99.1 (Investor Presentation, dated September 2018) for specific financial data, as it is not included in the main text.
- Confirm the current status of the company, as the filing notes the registrant is an emerging growth company.
- Note that the presentation materials are not legally "filed" and may not be incorporated by reference in other filings.
- Check for subsequent filings to see if the company has updated the information contained in the September 2018 presentation.